38 novel benzo[d]isoxazoles were synthesised and evaluated for anti-TB activity.
4 analogues (MIC < 30 μM) exhibited very good anti-TB activity against 3 MTB strains.
In vitro cytotoxicity studies of the most active compounds were analysed.
All compounds docking scores displayed in between −7.1 and −10.7 kcal/mol.
Compound 7j was docking with mycobacterial PS enzyme (4MQ6.pdb).